Hyperprolactinemia
Conditions
Interventions
control group:pseudo rTMS
Sponsors
Fuzhou Neuropsychiatric Hospital Affiliated to Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of schizophrenia in DSM-V. 2. Patients with a course of more than 2 years; 3. Patients aged from 18 to 59 years, regardless of gender; 4. The dose of risperidone was stable for more than 4 weeks before the trial in patients who received risperidone for more than 3 months; 5. It is forbidden to use other antipsychotics, antidepressants and mood stabilizers, and it is allowed to use benzodiazepines in combination. 6. The PANSS scale was used to evaluate, and the total score reached the stable standard (PANSS 414.00uiu/ml.
Exclusion criteria
Exclusion criteria: 1. Patients with severe organic diseases or hepatic and renal dysfunction; 2. Patients with brain lesion and cranial cerebral injury history; 3. Patients with previous alcohol abuse or psychoactive substance abuse history; 4. Patients with mental retardation, personality disorders, or any other mental disorders. 5. Patients received MECT within one month of study. 6. Patients diagnosed with epilepsy, exhibited abnormal electroencephalogram activity, or reported family history with epilepsy; Patient with intracranial metallic material implant or pacemaker; 7. Patients who are pregnant, intends to be pregnant, or breastfeeding; 8. Patients who show positive results on pregnancy tests.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prolactin values; | — |
Countries
China
Contacts
Public ContactMinjian Zheng
Fuzhou neuropsychiatric Hospital Affiliated to Fujian Medical University
Outcome results
None listed